Genfit SA Publishes 2025 Shareholder Letter
Genfit SA's 2025 shareholder letter announces the voluntary delisting of its American Depositary Shares from Nasdaq to streamline operations. The company reports a cash runway extending beyond 2028, supported by partnerships and cost reductions. It emphasizes a diversified pipeline and increased visibility at a global hepatology congress. The letter is available online.
Genfit SA has published a new shareholder letter dated December 2, 2025. The letter outlines recent developments, including the company’s decision to voluntarily delist its American Depositary Shares from the Nasdaq Global Select Market to streamline operations and focus resources. Financial updates indicate an extended cash runway beyond the end of 2028, supported by milestone payments from partnerships and cost reductions following the discontinuation of a program. The letter also highlights the company’s ongoing strategy to maintain a diversified pipeline and notes increased visibility at a recent global hepatology congress. The full letter can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfit SA published the original content used to generate this news brief on December 02, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
